NanoFUSE Biologics的封面图片
NanoFUSE Biologics

NanoFUSE Biologics

医疗设备制造业

Malden,Massachusetts 1,243 位关注者

Regenerative therapeutic that has the properties of replacing or "regenerating" human bone cells to form normal bone.

关于我们

NanoFuse Biologics LLC, wholly owned by NANISX LLC (a KIC Ventures portfolio company), features NanoFuse? DBM, the first FDA-approved combination of synthetic bioactive ceramic 45S5 bioglass and demineralized bone matrix (DBM) for bone regeneration, promoting fusion and healing. When combined with aqueous body fluid, NanoFuse forms a 3D ultra-porous calcium hydroxyapatite layer within 24 hours, creating a strong bond with adjacent bone. This process triggers osteoblast differentiation, accelerates osteogenesis, and enhances bone growth. Additionally, in vitro studies show ionic release (Ca) and pH changes inherent to bioactive glass create an unfavorable environment for microbes, adding an antimicrobial benefit. Guided by LESS? Exposure Spine Surgery (LESS) principles and the Restore Function, Early Intervention, and Preserve Anatomy (REP) methodology, NanoFuse Biologics is a trusted bone void filler for fusion and regeneration. With a proven clinical record and patented manufacturing, NanoFuse Biologics LLC delivers a reliable bone regeneration solution.

网站
https://www.nanofusebiologics.com/
所属行业
医疗设备制造业
规模
11-50 人
总部
Malden,Massachusetts
类型
私人持股
创立
2018

地点

NanoFUSE Biologics员工

动态

相似主页

查看职位